Literature DB >> 24999356

Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Jong-In Park1.   

Abstract

The Raf/MEK/extracellular signal-regulated kinase (ERK) pathway has a pivotal role in facilitating cell proliferation, and its deregulated activation is a central signature of many epithelial cancers. However paradoxically, sustained activity of Raf/MEK/ERK can also result in growth arrest in many different cell types. This anti-proliferative Raf/MEK/ERK signaling also has physiological significance, as exemplified by its potential as a tumor suppressive mechanism. Therefore, significant questions include in which cell types and by what mechanisms this pathway can mediate such an opposing context of signaling. Particularly, our understating of the role of ERK1 and ERK2, the focal points of pathway signaling, in growth arrest signaling is still limited. This review discusses these aspects of Raf/MEK/ERK-mediated growth arrest signaling.

Entities:  

Keywords:  ERK1/2; MEK1/2; Raf; growth arrest; non-kinase effect; proliferation

Year:  2014        PMID: 24999356      PMCID: PMC4079089          DOI: 10.1007/s11515-014-1299-x

Source DB:  PubMed          Journal:  Front Biol (Beijing)        ISSN: 1674-7984


  97 in total

Review 1.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

2.  Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.

Authors:  Jong-In Park; Christopher J Strock; Douglas W Ball; Barry D Nelkin
Journal:  Cytokine       Date:  2004-12-01       Impact factor: 3.861

3.  Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.

Authors:  Kimberly A Burkhard; Fengming Chen; Paul Shapiro
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.

Authors:  Rebecca S Sippel; Jennifer E Carpenter; Muthusamy Kunnimalaiyaan; Sara Lagerholm; Herbert Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-08       Impact factor: 4.052

6.  Identification of Tyr-185 as the site of tyrosine autophosphorylation of recombinant mitogen-activated protein kinase p42mapk.

Authors:  A J Rossomando; J Wu; H Michel; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels.

Authors:  Renaud Lefloch; Jacques Pouysségur; Philippe Lenormand
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

8.  Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion.

Authors:  Catherine L Olsen; Betty Gardie; Paul Yaswen; Martha R Stampfer
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

9.  Medullary thyroid carcinoma: targeted therapies and future directions.

Authors:  Scott N Pinchot; Muthusamy Kunnimalaiyaan; Rebecca S Sippel; Herbert Chen
Journal:  J Oncol       Date:  2009-12-24       Impact factor: 4.375

Review 10.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09
View more
  23 in total

1.  Active ERK2 is sufficient to mediate growth arrest and differentiation signaling.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Seung-Hee Yoon; Jong-In Park
Journal:  FEBS J       Date:  2015-02-03       Impact factor: 5.542

2.  Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.

Authors:  Jin-Hwan Kim; Seung-Keun Hong; Pui-Kei Wu; Alexsia L Richards; William T Jackson; Jong-In Park
Journal:  Exp Cell Res       Date:  2014-08-14       Impact factor: 3.905

3.  Fine particle matters induce DNA damage and G2/M cell cycle arrest in human bronchial epithelial BEAS-2B cells.

Authors:  Jing Wu; Yanfeng Shi; Collins Otieno Asweto; Lin Feng; Xiaozhe Yang; Yannan Zhang; Hejing Hu; Junchao Duan; Zhiwei Sun
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-18       Impact factor: 4.223

4.  ERK1/2 can feedback-regulate cellular MEK1/2 levels.

Authors:  Seung-Keun Hong; Pui-Kei Wu; Mansi Karkhanis; Jong-In Park
Journal:  Cell Signal       Date:  2015-07-09       Impact factor: 4.315

5.  Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Jong-In Park
Journal:  Mol Cell Biol       Date:  2017-08-28       Impact factor: 4.272

6.  A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.

Authors:  Seung-Keun Hong; Pui-Kei Wu; Jong-In Park
Journal:  Cell Signal       Date:  2017-10-03       Impact factor: 4.315

7.  Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.

Authors:  D Starenki; S-K Hong; R V Lloyd; J-I Park
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

8.  Convergent Effects of Resveratrol and PYK2 on Prostate Cells.

Authors:  Andrea Conte; Annamaria Kisslinger; Claudio Procaccini; Simona Paladino; Olimpia Oliviero; Francesca de Amicis; Deriggio Faicchia; Dominga Fasano; Marilena Caputo; Giuseppe Matarese; Giovanna Maria Pierantoni; Donatella Tramontano
Journal:  Int J Mol Sci       Date:  2016-09-13       Impact factor: 5.923

9.  Suppression of B-Raf(V600E) cancers by MAPK hyper-activation.

Authors:  Rawan Atiq; Rachel Hertz; Sophia Eldad; Elia Smeir; Jacob Bar-Tana
Journal:  Oncotarget       Date:  2016-04-05

Review 10.  Antioxidant and Signal-Modulating Effects of Brown Seaweed-Derived Compounds against Oxidative Stress-Associated Pathology.

Authors:  Rahima Begum; Saurav Howlader; A N M Mamun-Or-Rashid; S M Rafiquzzaman; Ghulam Md Ashraf; Ghadeer M Albadrani; Amany A Sayed; Ilaria Peluso; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Oxid Med Cell Longev       Date:  2021-07-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.